
Director of the Gamaleya Research Center for Epidemiology and Medicine, Denis Logunov, announced the administration of the Russian antitumor vaccine against melanoma to two patients.
AI-generated summary
In April, a patient with cutaneous melanoma received the Neooncovac mRNA vaccine for the first time in clinical practice.
Denis Logunov, director of the N. F. Gamaleya Research Center for Epidemiology and Epidemiology of the Russian Ministry of Health, said that two patients have already been administered the Russian vaccine against melanoma.
In April, a patient with cutaneous melanoma received the personalized antitumor mRNA vaccine “Neoonkovak” for the first time at the National Medical Research Center of Radiology of the Russian Ministry of Health.
EKATERINBURG, September 15 - RIA Novosti. Two patients have already received the Russian vaccine against skin cancer, said Denis Logunov, director of the National Research Center for Epidemiology and Microbiology named after Honorary Academician N. F. Gamaleya of the Ministry of Health of the Russian Federation.
“Currently, the oncology vaccine has been developed only against melanoma. This is one type of tumor... And this year we have already administered it to two patients,” Logunov said at the “Knowledge.First” marathon as part of the International Youth Festival.
In April, at the National Medical Research Center of Radiology of the Russian Ministry of Health, a patient with skin melanoma was given the personalized antitumor mRNA vaccine “Neoonkovak” for the first time in clinical practice. The project for its creation was implemented in collaboration between the National Medical Research Center of Radiology of the Russian Ministry of Health and the N. F. Gamaleya National Research Center for Epidemiology and Medicine of the Russian Ministry of Health.

Regular reading for pleasure is associated with a slower decline in cognitive abilities and a lower risk of dementia in old age, scientists at the University of Cambridge have found.

Russian schoolchildren are massively taking the antiviral drug Rimantadine due to a trend on TikTok for the sake of hallucinations. Narcologists warn about the danger of the drug for the central nervous system.

Influenza vaccines with a completely updated composition have begun to arrive in Russian regions, replacing all three strains compared to the last epidemic season.

Ruskin oncologist Justin Stebbing said the bacterium Helicobacter pylori can increase the risk of developing bowel cancer by about 1.6 times, although it is not the main cause.

The company "PSK Pharma" received a registration certificate for "Bosentan PSK" - the first Russian generic drug for the treatment of pulmonary arterial hypertension in patients from three months of age.

Cardiologist Diego Araiza said that during menopause, women's risk of heart disease increases significantly due to a drop in levels of estrogen, which protects the arteries.